User Profile
Corporate
Careers
FAQ
Blog
Pricing
Social
General Modals
Advanced Modals
Search
Wizards
Career Development Award
Those participating in clinical trials should resemble the people who are most likely to get the diseases being studied. Right now, that’s not happening. Despite representing a large portion of the U.S. population, only a small portion of underrepresented communities are involved in clinical trials. Winn CDA looks to change this.
Improving participation in clinical trials isn’t just a nice idea, it’s a powerful tool for driving better health outcomes. It helps us learn how new medicines work for different people, and tailor treatments to them. It also gives us a range of data that can help doctors make better choices when treating patients. Finally, it’s a crucial step toward improving the health and lives of all communities.
The Robert A. Winn Excellence in Clinical Trials: Career Development Award (Winn CDA), supported by the Bristol Myers Squibb Foundation, is a 2-yr program designed to support the career development of early-stage investigator physicians who have a demonstrated commitment to transforming and expanding access to the clinical research landscape. They will become community-oriented clinical trialists who will drive improved health outcomes through their research and mentoring. Currently, our clinical research areas include cancer, cardiovascular disease and immunologic disorders.
Deadline: May 12, 2025
Specialties
Eligibility Requirements
While physicians from groups underrepresented in medicine are highly encouraged to apply, you do not have to fall under the URiM population to participate in this program. If you have a demonstrated commitment (reflected in your CV or past publications) to increasing diverse patient populations in clinical trials, you may be eligible to apply.
Eligible candidates will need to be US Citizens, Lawful Permanent Residents (LPRs) as defined by the US Department of Homeland Security or hold a H-1B or O-1 Visa. The Visa must be valid during the full program period.
New or early stage investigators are eligible to apply for the Winn CDA program. As defined by the National Institutes of Health (NIH), a new investigator has completed his or her terminal research degree or medical residency—whichever date is later—within the past 10 years and has not yet competed successfully for a substantial, competing NIH research grant. Applicants with an RO1 or RO1 equivalent are ineligible.
Eligible Countries:
Sponsor Details
Sponsor Institute/Organizations: Robert A. Winn Diversity in Clinical Trials Award Program
Sponsor Type:
Address: NA
Legal & Affiliation Disclaimer
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Grant
Letter Of Intent Deadline:
May 12, 2025
Final Deadline:
May 12, 2025
Funding Amount:
$240,000
Host Details
Affiliation: Robert A. Winn Diversity in Clinical Trials Award Program
Address: NA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.
Questions and Answers
Commonly asked questions about this funding opportunity from the host and other attendees.
Invite Gmail Contacts